Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Hogan

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Pathology|February 2, 2021
Pitfalls in the assessment of disseminated intravascular coagulation in patients on dabigatranGurbaksh Singh Kanda, Wai Khoon Ho, Christopher Rodrigues, et al.
BMJ (Clinical Research Ed.)|January 21, 2025
A change in voiceChris Hogan, Marion Alston, Andrew Costerton, et al.
Archives of Dermatology|August 19, 2009
Antioxidant effect of warfarin therapy: a possible symptomatic treatment for erythropoietic protoporphyriaIngrid Winship, Gayle Ross, Amanda Nicoll, et al.
Seminars in Thrombosis and Hemostasis|December 28, 2020
Research Trends in Anticoagulation Therapy over the Last 25 YearsMustafa K Mian, Subhashaan Sreedharan, Neeraj S Limaye, et al.
Trials|August 11, 2023
Rotational ThromboElastometry-guided blood component administration versus standard of care in patients with Cirrhosis and coagulopathy undergoing Invasive ProcEdures (RECIPE): study protocol for a randomised controlled trialNatasha Janko, Ammar Majeed, William Kemp, et al.
The Annals of Thoracic Surgery|February 21, 2006
Recombinant activated factor VII: treating postoperative hemorrhage in cardiac surgeryConrad V Bishop, William E P Renwick, Chris Hogan, et al.
Transfusion|January 24, 2016
Cytomegalovirus in Australian blood donors: seroepidemiology and seronegative red blood cell component inventoriesDaniel V Lancini, Helen M Faddy, Sue Ismay, et al.
The Australasian Journal of Dermatology|March 28, 2019
Warfarin ineffective as symptomatic therapy for erythropoietic protoporphyriaBrent J Doolan, Mi Vu, George A Varigos, et al.
Journal of the Air & Waste Management Association (1995)|January 5, 2016
Generating a geospatial database of U.S. regional feedstock production for use in evaluating the environmental footprint of biofuelsChristopher T Holder, Joshua C Cleland, Stephen D LeDuc, et al.
Transfusion|February 3, 2017
A national review of the clinical use of group O D- red blood cell unitsRena Hirani, Janet Wong, Perfecto Diaz, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Pathology|February 2, 2021
Pitfalls in the assessment of disseminated intravascular coagulation in patients on dabigatranGurbaksh Singh Kanda, Wai Khoon Ho, Christopher Rodrigues, et al.
BMJ (Clinical Research Ed.)|January 21, 2025
A change in voiceChris Hogan, Marion Alston, Andrew Costerton, et al.
Archives of Dermatology|August 19, 2009
Antioxidant effect of warfarin therapy: a possible symptomatic treatment for erythropoietic protoporphyriaIngrid Winship, Gayle Ross, Amanda Nicoll, et al.
Seminars in Thrombosis and Hemostasis|December 28, 2020
Research Trends in Anticoagulation Therapy over the Last 25 YearsMustafa K Mian, Subhashaan Sreedharan, Neeraj S Limaye, et al.
Trials|August 11, 2023
Rotational ThromboElastometry-guided blood component administration versus standard of care in patients with Cirrhosis and coagulopathy undergoing Invasive ProcEdures (RECIPE): study protocol for a randomised controlled trialNatasha Janko, Ammar Majeed, William Kemp, et al.
The Annals of Thoracic Surgery|February 21, 2006
Recombinant activated factor VII: treating postoperative hemorrhage in cardiac surgeryConrad V Bishop, William E P Renwick, Chris Hogan, et al.
Transfusion|January 24, 2016
Cytomegalovirus in Australian blood donors: seroepidemiology and seronegative red blood cell component inventoriesDaniel V Lancini, Helen M Faddy, Sue Ismay, et al.
The Australasian Journal of Dermatology|March 28, 2019
Warfarin ineffective as symptomatic therapy for erythropoietic protoporphyriaBrent J Doolan, Mi Vu, George A Varigos, et al.
Journal of the Air & Waste Management Association (1995)|January 5, 2016
Generating a geospatial database of U.S. regional feedstock production for use in evaluating the environmental footprint of biofuelsChristopher T Holder, Joshua C Cleland, Stephen D LeDuc, et al.
Transfusion|February 3, 2017
A national review of the clinical use of group O D- red blood cell unitsRena Hirani, Janet Wong, Perfecto Diaz, et al.
Pageof 3